The Asthma and Allergy Foundation of America (AAFA) is sharing this press release from the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting to bring you the latest research news quickly. This year’s meeting was held Feb. 25 – 28. [PRESS RELEASE] COVID-19 Vaccination Well-tolerated in Patients with Mast Cell Activation Syndrome Study presented at the 2022 AAAAI Annual Meeting also suggests vaccine hesitancy is higher among this group of patients than the…
Lesen Sie weiter auf: People With Mast Cell Activation Syndrome (MCAS) Can Tolerate COVID-19 Vaccines
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik by Asthma and Allergy Foundation of America (AAFA)
Kommentare und Fragen
Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!Weiteres von Asthma and Allergy Foundation of America
- AAFA Marks Day of Remembrance for Lives Lost to Asthma and Allergies
- How to Avoid Allergy and Asthma Triggers During Outdoor Parties and Cookouts
- Understanding Eosinophilic Asthma
- Tips on How to Use Your Inhaler to Get More Medicine Into Your Lungs for Better Asthma Control
- Advocacy Action Day for People With Asthma and Allergies
- Healthier Home Checklist: How to Improve Your Home’s Asthma and Allergy Hot Spots
- Ask the Expert Chat: How to Use Your Asthma and Allergy Medicines
- Top Questions About Using Asthma and Allergy Medicines
- Air Quality Awareness Sheds Light on How Environmental Injustice Affects People With Asthma
- The HEAL Program: AAFA’s Commitment to Health Equity for People With Asthma
-
Produkthinweis*
Beurer LR 500 Luftreiniger mit 3-Stufen-Filterung, zuschaltbarem UV-Licht und komfortabler App-Steuerung über WLAN (421)
* = Affiliate Links / Bilder von der Amazon Product Advertising API / Aktualisiert am: 29.05.2022
